# Role of Perfusion CT in Pancreatic Cancer

> **NCT01703650** · — · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 48 (actual)

## Conditions studied

- Adenocarcinoma, Pancreas
- Neuroendocrine Carcinoma of Pancreas

## Interventions

- **DRUG:** iopromide
- **PROCEDURE:** CT

## Key facts

- **NCT ID:** NCT01703650
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-11
- **Primary completion:** 2015-12
- **Final completion:** 2021-09
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2020-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01703650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01703650, "Role of Perfusion CT in Pancreatic Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01703650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*